In This Article:
We recently published a list of Pulse of the Market: Wednesday’s 10 Top Performers. In this article, we are going to take a look at where ADMA Biologics Inc. (NASDAQ:ADMA) stands against other Wednesday’s top performers.
The stock market regained momentum on Wednesday, with all main indices ending in the green, as investors cheered the Federal Reserve’s decision to keep interest rates unchanged.
The tech-heavy Nasdaq led the gains, rallying 1.41 percent, followed by the S&P 500 with a 1.08 percent gain, and the Dow Jones, by 0.92 percent.
Optimism spilled over into companies, with 10 particularly leading the charge. In this article, we have identified Wednesday’s 10 best performers and detailed the reasons behind their gains.
To come up with the list, we considered only the companies with a $2-billion market capitalization and $5 million in trading volume.
An independent distributor in their pharmacy with a range of biopharmaceutical products on display.
ADMA Biologics Inc. (NASDAQ:ADMA)
ADMA Biologics extended its winning streak for a fourth straight day on Wednesday, adding 10.16 percent to finish at $20.61 apiece in line with the overall market rally, further supported by a bullish outlook and impressive earnings performance last year.
In its latest earnings results, ADMA said it swung to a net income of $112 million in the fourth quarter of 2024 from a $17.6 million net loss in the same period a year earlier. Revenue, on the other hand, spiked by 58 percent to $117 million from $73.9 million year-on-year.
For the full year, ADMA registered a $197.67 million net profit, reversing a $28.2 million net loss in 2023, as revenues jumped by 79.8 percent to $426 million from $258 million.
For this year, ADMA expects revenues to end at $490 million and increase to $605 million in 2026, with adjusted net income targeted at $175 million and $235 million, respectively.
Overall, ADMA ranks 3rd on our list of Wednesday’s top performers. While we acknowledge the potential of ADMA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as ADMA but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. This article is originally published at Insider Monkey.